|
Product
|
MCP-4/CCL13, Human
|
|
Cat#
|
101-27-13A
|
|
Sequence
|
QPDALNVPST CCFTFSSKKI SLQRLKSYVI TTSRCPQKAV
IFRTKLGKEI CADPKEKWVQ NYMKHLGRKA HTLKT
|
|
Unit/Weight
|
20 μg
|
|
Unit Price
|
$152.00
|
|
Description
|
CCL13 is a chemoattractant for monocytes and eosinophils, and activates basophils. In addition, it has been reported to be chemotactic for CD4+ and CD8+ T cells, with an activity almost equivalent to that of MCP-3. The bioactivities of CCL13 is most likely mediated by the CC chemokine receptors CCR-2 and CCR-3, both of which have been shown to bind CCL13.
|
|
Molecular Weight
|
Approximately 8.6 kDa, a single non-glycosylated polypeptide chain containing 75 amino acids.
|
|
Purity
|
> 96 % by SDS-PAGE and HPLC analyses.
|
|
Storage
|
This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
|
|